Autopsy report · NCT05547412

Validation of Velocity Curvature Index as a Diagnostic Biomarker Tool for Assessment of Large Vessel Stroke

“enrollment, administrative/finance”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 4 months before it stopped.
• 27 participants enrolled.
• Results were posted on the registry 1 year 2 months after it ended.

Vital statistics

Status

Terminated

Sponsor

NeuraSignal Inc dba NovaSignal

Sponsor type

Industry

Conditions

Stroke; Acute Ischemic Stroke

Interventions

NovaGuide 2 Intelligent Ultrasound System

Participants

27

Sites

1

Countries

United States

Trials that died the same way

• Registry for Patients Undergoing Pulmonary Procedures
  “funding/ enrollment” (79% match in meaning)
• Early Childhood Obesity Among Rural Residents of West Texas
  “Enrollment issues” (68% match in meaning)
• Effect on Pain and Inflammation With DEXTENZA Treatment in Patients Undergoing Intravitreal Anti-VEGF Injections
  “Subject Enrollment” (67% match in meaning)
• The Safety of Transdermal Nicotine Immediately Following an Acute Coronary Syndrome
  “Difficulties with enrollment.” (66% match in meaning)
• ALgorithms Adapted From Remote Monitoring
  “Low enrollment, completion of funding” (65% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.